Ikena Oncology, Inc. - stock earnings
IKNA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -19.5 million USD | 659000 USD |
| 2023Q3 | -17.3 million USD | 1.2 million USD |
| 2023Q2 | -17.1 million USD | 2.0 million USD |
| 2023Q1 | -12.9 million USD | 5.3 million USD |
| 2022Q4 | -13.1 million USD | 5.5 million USD |
| 2022Q3 | -16.8 million USD | 6.4 million USD |
| 2022Q2 | -20.0 million USD | 382000 USD |
| 2022Q1 | -16.7 million USD | 3.4 million USD |
| 2021Q4 | 2.8 million USD | 20.2 million USD |
| 2021Q3 | -14.5 million USD | 3.7 million USD |
| 2021Q2 | -12.7 million USD | 3.5 million USD |
| 2021Q1 | -9.7 million USD | 3.5 million USD |
| 2020Q4 | -26.1 million USD | 65000 USD |
| 2020Q3 | -6.2 million USD | 2.8 million USD |
| 2020Q2 | -5.0 million USD | 3.1 million USD |
| 2020Q1 | -6.9 million USD | 3.2 million USD |
IKNA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -68.2 million USD | 9.2 million USD |
| 2022 | -66.6 million USD | 15.6 million USD |
| 2021 | -34.1 million USD | 31.0 million USD |
| 2020 | -44.3 million USD | 9.2 million USD |
| 2019 | -16.8 million USD | 13.8 million USD |
| 2018 | -40.9 million USD | 990000 USD |
IKNA
Price: $1.30
52 week price:
Earnings Per Share: -1.63 USD
P/E Ratio: -0.93
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 7489
Market Capitalization: 61.3 million